The study found a correlation between Tn-MUC1 expression and poor prognosis in ICC patients and developed effective CAR T cells specifically targeting Tn-MUC1-positive ICC tumors. This evidence concerns the gene MUC1 and intrahepatic cholangiocarcinoma.